馬鞍山鋼鐵股份(00323.HK)向華寶投資轉讓華寶租賃3.11%股權
格隆匯10月28日丨馬鞍山鋼鐵股份(00323.HK)公吿,2022年10月28日,公司的全資附屬公司馬鋼香港公司與華寶投資簽訂股權轉讓協議,據此,馬鋼香港公司向華寶投資轉讓華寶租賃的3.11%股權,總作價為人民幣8863.5萬元。
華寶租賃主要從事融資租賃業務;租賃業務;向國內外購買租賃財產;租賃財產的殘值處理及維修;租賃交易諮詢和擔保;及從事與主營業務有關的商業保理業務。
華寶租賃業務屬於非鋼產業,此次股權轉讓後可進一步優化存量資產,補充流動資金,更好的支援公司鋼鐵主業建設,實現資產價值最大化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.